Artiva Biotherapeutics Ratios (2023-2025) | ARTV

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -1,683.13%42.13%-484.55%-5,514.74%
EBIT Margin -1,786.57%40.56%-509.36%-5,773.71%
EBITDA Margin -1,688.59%42.85%-508.98%-5,603.19%
Operating Margin -1,786.57%40.56%-509.36%-5,773.71%
Net Margin -1,683.13%42.13%-484.55%-5,514.74%
FCF Margin -40.99%-481.32%-6,017.53%
Efficiency
Assets Average 150.75M217.59M200.42M180.33M159.13M
Equity Average -157.85M-156.73M-168.34M-182.88M4.95M193.82M177.71M158.91M139.13M
Invested Capital -164.25M-151.45M-162.01M-174.67M-191.10M201.00M186.64M168.78M149.04M129.22M
Leverage & Solvency
Equity Ratio -1.54-2.520.890.890.880.880.87
Valuation
Enterprise Value -53.70M-65.89M42.67M-48.20M73.09M228.61M59.41M-228.47M-219.51M-150.36M
Market Capitalization 375.24M244.84M73.09M36.79M70.10M
Return Ratios
Return on Sales -1.01%
Return on Capital Employed -0.44%-0.33%
Return on Assets -0.38%-0.28%
Return on Equity 0.18%0.16%-11.56%-0.32%